Clinicopathological features | circNEIL3 expression | P value | miR-432-5p expression | P value | ADAR1 expression | P value | |||
---|---|---|---|---|---|---|---|---|---|
High | Low | High | Low | High | Low | ||||
All cases | 52 | 52 | Â | 52 | 52 | Â | 52 | 52 | Â |
Gender | Â | Â | 0.676 | Â | Â | 0.012* | Â | Â | 0.676 |
 Male | 36 | 34 |  | 29 | 41 |  | 34 | 36 |  |
 Female | 16 | 18 |  | 23 | 11 |  | 18 | 16 |  |
Age (year) | Â | Â | 0.527 | Â | Â | 0.527 | Â | Â | 0.527 |
 < 60 | 18 | 15 |  | 18 | 15 |  | 15 | 18 |  |
 ≥ 60 | 34 | 37 |  | 34 | 37 |  | 37 | 34 |  |
Serum CA199 (U/ml) | Â | Â | 0.129 | Â | Â | 0.319 | Â | Â | 0.292 |
 < 39 | 7 | 10 |  | 11 | 6 |  | 7 | 10 |  |
 ≥ 39 | 31 | 36 |  | 33 | 34 |  | 32 | 35 |  |
 ≥ 1000 | 14 | 6 |  | 8 | 12 |  | 13 | 7 |  |
Diameter (cm) | Â | Â | 0.098 | Â | Â | 0.033* | Â | Â | 0.033* |
 ≤ 4 | 37 | 44 |  | 45 | 36 |  | 36 | 45 |  |
 > 4 | 15 | 8 |  | 7 | 16 |  | 16 | 7 |  |
Location | Â | Â | 0.094 | Â | Â | 0.403 | Â | Â | 0.676 |
 Head | 39 | 31 |  | 37 | 33 |  | 36 | 34 |  |
 Body and tail | 13 | 21 |  | 15 | 19 |  | 16 | 18 |  |
Histological grade | Â | Â | 0.543 | Â | Â | 0.311 | Â | Â | 0.203 |
 I/ I-II | 34 | 31 |  | 35 | 30 |  | 32 | 33 |  |
 II/ II-III/ III | 18 | 21 |  | 17 | 22 |  | 20 | 19 |  |
Microscopic vascular invasion | Â | Â | 0.02* | Â | Â | 0.527 | Â | Â | 0.833 |
 Present | 41 | 30 |  | 34 | 37 |  | 35 | 36 |  |
 Absent | 11 | 22 |  | 18 | 15 |  | 17 | 16 |  |
Microscopic nerve invasion | Â | Â | 0.014* | Â | Â | 0.066 | Â | Â | 0.22 |
 Present | 50 | 42 |  | 49 | 43 |  | 48 | 44 |  |
 Absent | 2 | 10 |  | 3 | 9 |  | 4 | 8 |  |
T stage | Â | Â | 0.168 | Â | Â | 0.844 | Â | Â | 0.554 |
 T1/T2 | 25 | 32 |  | 29 | 28 |  | 27 | 30 |  |
 T3/T4 | 27 | 20 |  | 23 | 24 |  | 25 | 22 |  |
N stage | Â | Â | 0.325 | Â | Â | 0.554 | Â | Â | 0.076 |
 N0 | 21 | 26 |  | 22 | 25 |  | 28 | 19 |  |
 N1/N2 | 31 | 26 |  | 30 | 27 |  | 24 | 33 |  |
M stage | Â | Â | 0.475 | Â | Â | 0.475 | Â | Â | 0.475 |
 M0 | 50 | 52 |  | 52 | 50 |  | 50 | 52 |  |
 M1 | 2 | 0 |  | 0 | 2 |  | 2 | 0 |  |
Clinical stage | Â | Â | 0.146 | Â | Â | 0.534 | Â | Â | 0.299 |
 I-IIa | 14 | 21 |  | 16 | 19 |  | 20 | 15 |  |
 IIb-IV | 38 | 31 |  | 36 | 33 |  | 32 | 37 |  |